Cara Therapeutics
Biotechnology company focused on developing therapeutics to treat diseases associated with pain and inflammation. Learn more
Launch date
Employees
Market cap
$14.8m
Enterprise valuation
($34m) (Public information from Sep 2024)
Share price
$0.309 CARA
Company register number SC277874
Stamford Connecticut (HQ), Glasgow Scotland (founding location)
Authorizing premium user...